287 related articles for article (PubMed ID: 16919027)
41. Expression of stem cell markers Nanog and Nestin in lip squamous cell carcinoma and actinic cheilitis.
Scotti FM; Mitt VC; Vieira DS; Biz MT; Castro RG; Modolo F
Oral Dis; 2018 Oct; 24(7):1209-1216. PubMed ID: 29761881
[TBL] [Abstract][Full Text] [Related]
42. Actinic cheilitis: a premalignant condition.
Manganaro AM; Will MJ; Poulos E
Gen Dent; 1997; 45(5):492-4. PubMed ID: 9515418
[TBL] [Abstract][Full Text] [Related]
43. Thioredoxin and metallothionein: Homeostasis-related proteins in lip carcinogenesis.
Caldeira PC; Silva LS; Batista AC; Aguiar MC
Arch Oral Biol; 2017 May; 77():75-81. PubMed ID: 28183007
[TBL] [Abstract][Full Text] [Related]
44. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
45. Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma.
Costa NL; Gonçalves AS; Martins AF; Arantes DA; Silva TA; Batista AC
J Oral Pathol Med; 2016 Jul; 45(6):418-24. PubMed ID: 26514660
[TBL] [Abstract][Full Text] [Related]
46. Relationship of immunohistochemistry scores of altered p53 protein expression in relation to patient's habits and histological grades and stages of squamous cell carcinoma.
Bukhari MH; Niazi S; Chaudhry NA
J Cutan Pathol; 2009 Mar; 36(3):342-9. PubMed ID: 19220630
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of new immunohistochemistry scoring of p53 protein expression in cutaneous squamous cell carcinoma of mice.
Bukhari MH; Niazi S; Anwar M; Chaudhry NA; Naeem S
Ann N Y Acad Sci; 2008 Sep; 1138():1-9. PubMed ID: 18837875
[TBL] [Abstract][Full Text] [Related]
48. p53 and MDM2 protein expression in actinic cheilitis.
de Freitas Mda C; Ramalho LM; Xavier FC; Moreira AL; Reis SR
J Appl Oral Sci; 2008; 16(6):414-9. PubMed ID: 19082401
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of specific modified histones in lip carcinogenesis.
de Freitas Filho SAJ; Servato JPS; de Sá RT; Siqueira CS; de Faria PR; Loyola AM; Cardoso SV
Pathol Res Pract; 2018 Jun; 214(6):876-880. PubMed ID: 29699903
[TBL] [Abstract][Full Text] [Related]
50. Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis.
Gonçalves AS; Oliveira JP; Oliveira CF; Silva TA; Mendonça EF; Wastowski IJ; Batista AC
Hum Immunol; 2016 Sep; 77(9):785-90. PubMed ID: 26723902
[TBL] [Abstract][Full Text] [Related]
51. Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
Ferreira PS; Rocha L; Bezerra APC; Nico MMS; Lourenço SV
Oral Oncol; 2022 Feb; 125():105674. PubMed ID: 34929544
[TBL] [Abstract][Full Text] [Related]
52. Actinic cheilitis and carcinoma of the lip.
Main JH; Pavone M
J Can Dent Assoc; 1994 Feb; 60(2):113-6. PubMed ID: 8111655
[TBL] [Abstract][Full Text] [Related]
53. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
54. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects.
Vieira RA; Minicucci EM; Marques ME; Marques SA
An Bras Dermatol; 2012; 87(1):105-14. PubMed ID: 22481658
[TBL] [Abstract][Full Text] [Related]
55. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
56. CD8+ and FoxP3+ T-cell infiltration in actinic cheilitis.
Rojas IG; Spencer ML; Zapata PA; Martínez A; Alarcón R; Marchesani FJ; Tezal M
Int J Dermatol; 2017 Jan; 56(1):54-62. PubMed ID: 27778327
[TBL] [Abstract][Full Text] [Related]
57. Cheilitis glandularis: a clinical marker for both malignancy and/or severe inflammatory disease of the oral cavity.
Carrington PR; Horn TD
J Am Acad Dermatol; 2006 Feb; 54(2):336-7. PubMed ID: 16443070
[TBL] [Abstract][Full Text] [Related]
58. Surgical management of actinic cheilitis.
Satorres Nieto M; Gargallo Albiol J; Gay Escoda C
Med Oral; 2001; 6(3):205-17. PubMed ID: 11500638
[TBL] [Abstract][Full Text] [Related]
59. Laser Therapy for the Treatment of Actinic Cheilitis: A Systematic Review.
Ayen-Rodriguez A; Naranjo-Diaz MJ; Ruiz-Villaverde R
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457467
[TBL] [Abstract][Full Text] [Related]
60. Association of mast cell, eosinophil leucocyte and microvessel densities in actinic cheilitis and lip squamous cell carcinoma.
Souza LR; Fonseca-Silva T; Santos CC; Oliveira MV; Corrêa-Oliveira R; Guimarães AL; De Paula AM
Histopathology; 2010 Dec; 57(6):796-805. PubMed ID: 21166694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
